BETASERC 8MG 30 TABS - MADE IN FRANCE - FREE SHIPPING

Meniere's disease and syndrome, characterized by three main symptoms: dizziness, which is sometimes accompanied by nausea and vomiting; hearing loss (deafness); tinnitus;

symptomatic treatment of vestibular vertigo of various origins.

The active ingredient is betahistine dihydrochloride (one tablet contains 8 mg betahistine dihydrochloride).

Excipients: microcrystalline cellulose, beckons (E 421), citric acid monohydrate, colloidal anhydrous silicon dioxide, talc.

hypersensitivity to the active substance or to any of the excipients of the preparation ;

pheochromocytoma.

The daily dose for adults is 24-48 mg, evenly distributed for admission throughout the day. The tablets should be swallowed with water.

8 mg tablets - 1-2 tablets 3 times a day.

The dose should be selected individually, depending on the effect. A decrease in symptoms is sometimes only seen after a few weeks of treatment. The best results are sometimes obtained when the preparation is taken for several months. There is some evidence that prescribing treatment early in the disease prevents its progression or later hearing loss.

The preparation can be used regardless of food intake. Minor gastrointestinal upset may happen while taking this preparation , which can be improved by taking this preparation with food.

Pregnant

There is insufficient data on the use of betahistine in pregnant women. Betahistine should not be used during pregnancy, unless absolutely necessary.

It is not known whether betahistine passes into human breast milk. The benefits of using the preparation for the mother should be weighed against the benefits of breastfeeding and the potential risk to the baby.

Studies in rats have shown no effect on fertility.

Children

Due to the lack of data on the safety and efficacy of this preparation , it is not recommended to prescribe to children (under the age of 18).

Drivers

Betahistine is indicated for the treatment of Meniere's syndrome, which is characterized by a triad of main symptoms: dizziness, hearing loss, tinnitus, as well as for the symptomatic treatment of vestibular vertigo. Both conditions can negatively affect the ability to drive and operate machinery. According to clinical studies that studied the effect on the ability to drive a car and work with other mechanisms, betahistine did not affect or had an insignificant effect on this ability.

Several cases of preparation overdose are known. Some patients experienced mild to moderate symptoms (nausea, drowsiness, abdominal pain) after taking the preparation at a dose of up to 640 mg. More serious complications (convulsions, cardiopulmonary complications) were observed with the deliberate intake of high doses of betahistine, especially in combination with an overdose of other preparations.

Overdose treatment should include standard supportive measures.

The following adverse reactions have been observed in patients receiving this preparation during placebo-controlled studies.

From the gastrointestinal tract: frequent (≥ 1/100 to <1/10) - nausea and dyspepsia.

From the nervous system: frequent (≥ 1/100 to <1/10) - headache.

Store in its original packaging at a temperature not exceeding 25 ° C, out of the reach of children.

The shelf life is 5 years.